Vertex Pharmaceuticals Inc (VRTX)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-535,600	-479,800	-489,900	4,019,400	3,619,600	3,469,700	3,364,900	3,259,700	3,322,000	3,273,200	3,194,600	2,451,100	2,342,100	2,176,190	1,991,724	2,761,994	2,711,647	2,690,691	2,080,775	1,510,932
Total assets	US$ in thousands	22,533,200	22,240,200	20,132,100	23,917,400	22,730,200	21,726,200	20,349,200	18,974,200	18,150,900	16,706,400	15,582,200	14,256,100	13,432,500	12,618,700	12,221,700	12,115,100	11,751,800	11,301,600	10,216,400	8,893,200
ROA		-2.38%	-2.16%	-2.43%	16.81%	15.92%	15.97%	16.54%	17.18%	18.30%	19.59%	20.50%	17.19%	17.44%	17.25%	16.30%	22.80%	23.07%	23.81%	20.37%	16.99%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-535,600K ÷ $22,533,200K
= -2.38%

Vertex Pharmaceuticals Inc's return on assets (ROA) has shown fluctuations over the reported periods. The ROA increased from 16.99% as of March 31, 2020, to a peak of 23.81% as of September 30, 2020. Subsequently, there was a slight decline, with ROA ranging between 16.30% and 23.07% from June 2021 to December 2021.

As of June 30, 2022, the ROA increased to 20.50%, followed by some volatility ranging between 15.97% and 18.30% until December 31, 2022. However, there was a noticeable drop in ROA to 15.92% as of December 31, 2023.

The ROA then witnessed a recovery to 16.81% as of March 31, 2024; however, there was a significant decline to -2.43% by June 30, 2024, which continued to decrease to -2.38% as of December 31, 2024.

The negative trend in ROA observed in the latter part of 2024 warrants further investigation into the company's asset management efficiency and profitability performance during that period.